PARKER H STEWART

Insider Reports History

Location
Seattle, WA
Signature
/s/ Prathyusha Duraibabu, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PARKER H STEWART:

Company Role Class Num Shares Value Price $ Report Date Ownership
CODEXIS, INC. Director Common Stock 143,583 $361,829 $2.52 10 Jun 2025 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 112,600 $51,796 $0.4600 12 Jun 2025 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50,000 12 Jun 2025 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 12,789 16 Jun 2022 Direct

Insider Reports Filed by PARKER H STEWART

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 16:05
CDXS CODEXIS, INC. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:29
CDXS CODEXIS, INC. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 18:27
SGMO SANGAMO THERAPEUTICS, INC 04 Jun 2024 2 $0 4 Director 06 Jun 2024, 16:25
CDXS CODEXIS, INC. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:08
SGMO SANGAMO THERAPEUTICS, INC 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 16:51
CDXS CODEXIS, INC. 16 Dec 2022 1 $0 4 Director 20 Dec 2022, 15:41
CDXS CODEXIS, INC. 16 Dec 2022 0 $0 3 Director 20 Dec 2022, 15:41
/report/000120919122037951-parker-h-stewart-2022-06-16 IMPEL PHARMACEUTICALS INC 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 17:02
SGMO SANGAMO THERAPEUTICS, INC 01 Jun 2022 1 +$17,996 4 Director 03 Jun 2022, 16:18
SGMO SANGAMO THERAPEUTICS, INC 25 Feb 2022 2 $0 4 Director 01 Mar 2022, 16:12
/report/000120919121046570-parker-h-stewart-2021-07-11 IMPEL NEUROPHARMA INC 11 Jul 2021 1 $0 4 Director 13 Jul 2021, 17:09
/report/000120919121042478-parker-h-stewart-2021-04-27-restatement IMPEL NEUROPHARMA INC 27 Apr 2021 0 $0 4/A Director 22 Jun 2021, 17:47
/report/000120919121042473-parker-h-stewart-2021-04-22-restatement IMPEL NEUROPHARMA INC 22 Apr 2021 0 $0 3/A Director 22 Jun 2021, 17:41